When future historians look back on the 2020s, they will see it as a decade defined by—among other things—revolutionary artificial intelligence (AI) breakthroughs. While the hype for AI, particularly ...
Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer Artificial intelligence (AI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results